ClearPoint Neuro (CLPT) Total Debt Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.16% |
| Dec 31, 2025 | 14.44% |
| Sep 30, 2025 | 100.74% |
| Jun 30, 2025 | 100.24% |
| Dec 31, 2023 | 38.68% |
| Sep 30, 2023 | 38.71% |
| Jun 30, 2023 | 50.18% |
| Mar 31, 2023 | 52.79% |
| Dec 31, 2022 | 38.09% |
| Dec 31, 2021 | 35.79% |
| Sep 30, 2021 | 48.38% |
| Jun 30, 2021 | 41.50% |
| Mar 31, 2021 | 38.63% |
| Dec 31, 2020 | 86.00% |
| Sep 30, 2020 | -11.33% |
| Jun 30, 2020 | -27.59% |
| Mar 31, 2020 | 19.96% |
| Dec 31, 2019 | -19.72% |
| Sep 30, 2019 | -23.54% |
| Jun 30, 2019 | -21.62% |
| Mar 31, 2019 | -22.93% |
| Dec 31, 2018 | -23.90% |
| Sep 30, 2018 | -14.86% |
| Jun 30, 2018 | -27.85% |
| Mar 31, 2018 | -30.92% |
| Dec 31, 2017 | -13.75% |
| Dec 31, 2016 | 61.44% |